Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function.
Although it is now generally accepted that long-chain N-acylethanolamines and their precursors, N-acylethanolamine phospholipids, exist as trace constituents in virtually all vertebrate cells and tissues, their possible biological functions are just emerging. While anandamide (N-arachidonoylethanolamine) has received much attention due to its ability to bind to and activate cannabinoid receptors, the saturated and monounsaturated N-acylethanolamines, which usually represent the vast majority, are cannabinoid receptor-inactive but appear to interact with endocannabinoids and to have other signaling functions as well. Also, primary fatty acid amides, including the amide of oleic acid, which acts as a sleep-inducing agent, do not interact with cannabinoid receptors but are catabolically related to endocannabinoids. Here we review published information on the occurrence, metabolism, and possible signaling functions of the cannabinoid receptor-inactive N-acylethanolamines and primary fatty acid amides.
Schmid
H H O
HH
The Hormel Institute, University of Minnesota, 801-16th Avenue NE, Austin, MN 55912, USA. hoschmid@hi.umn.edu
Berdyshev
E V
EV
D000577:Amides / Q000378:metabolism*; D000818:Animals; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids / Q000378:metabolism; D015777:Eicosanoids / Q000378:metabolism; D004983:Ethanolamines / Q000378:metabolism*; D005227:Fatty Acids / Q000378:metabolism*; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug / Q000378:metabolism*
D000577:Amides; D063385:Cannabinoid Receptor Modulators; D002186:Cannabinoids; D015777:Eicosanoids; D004983:Ethanolamines; D005227:Fatty Acids; C022203:N-acylethanolamines; D043882:Receptors, Cannabinoid; D011955:Receptors, Drug